164 results
Page 2 of 9
6-K
EX-99.2
wu6lrey07
6 Sep 22
Condensed Consolidated Interim Financial Statements
12:42pm
6-K
EX-99.1
m1g4fcy
4 Aug 22
Current report (foreign)
11:41am
6-K
EX-99.2
z6tbh
4 Aug 22
Current report (foreign)
11:41am
6-K
EX-99.1
lu640 yd4s73c60
28 Jul 22
Current report (foreign)
2:52pm
6-K
EX-99
urbi6z 4v
26 Jul 22
Independent Laboratory Test Results Confirm Value of DermaPreciseTM Injection Consistency in Clinical Simulation Testing
1:45pm
6-K
EX-99.1
rc9x47cbgj5
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.4
lineveok9doekg
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.3
p78kbbr2l
10 May 22
Replicel Life Sciences Inc. Announces Application for a Management Cease Trade Order
4:34pm
6-K
EX-99.4
61bwrria9 vmcx81958
10 May 22
Replicel Life Sciences Inc. Announces Application for a Management Cease Trade Order
4:34pm
6-K
EX-99.1
lrucppcuvt3996 fi
29 Mar 22
RepliCel Announces Non-brokered Private Placement
1:02pm
6-K
EX-99.1
23w7x
29 Mar 22
RepliCel Announces Material Patent Milestones
12:51pm
6-K
EX-99.2
z99u7q2vgpgegyo4
21 Dec 21
51-102F3 Material Change Report
5:28pm
6-K
EX-99.3
oybpou4l1p nfdoim
21 Dec 21
51-102F3 Material Change Report
5:28pm
6-K
EX-99.2
a7yh9gg tjlw
30 Nov 21
Condensed Consolidated Interim Financial Statements
1:50pm
6-K
EX-99.1
ygjufv45emyoxk15
16 Nov 21
RepliCel’s Clinical Advisory Team Delivers Skin Rejuvenation Clinical Study Synopsis to its Japanese Regulatory and Clinical Study Management Team
4:03pm
6-K
EX-99.2
gkmsf5
16 Nov 21
RepliCel’s Clinical Advisory Team Delivers Skin Rejuvenation Clinical Study Synopsis to its Japanese Regulatory and Clinical Study Management Team
4:03pm
6-K
EX-99.1
n9gpub
2 Nov 21
RepliCel Announces Dermal Injector Update
12:31pm
6-K
EX-99.2
bcit852ofbl d0lw
2 Nov 21
RepliCel Announces Dermal Injector Update
12:31pm
6-K
EX-99.1
46vnl0x
21 Oct 21
Current report (foreign)
3:49pm